Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:56 AM
Ignite Modification Date: 2025-12-25 @ 11:10 PM
NCT ID: NCT00971867
Description: None
Frequency Threshold: 5
Time Frame: From the first infusion to the completion of study. Approximately up to 28 months
Study: NCT00971867
Study Brief: Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Paclitaxel Each vial (16.7 mL) contains 100 mg 0 None 3 11 11 11 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Interstitial Lung Disease SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA version 11.0 View
Vomitting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA version 11.0 View
Dyspnea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA version 11.0 View
Cancer Pain SYSTEMATIC_ASSESSMENT General disorders MedDRA version 11.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Alopecia SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA version 11.0 View
Hypoesthesia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA version 11.0 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA version 11.0 View
Weight Disorder SYSTEMATIC_ASSESSMENT General disorders MedDRA version 11.0 View
Nail Disorder SYSTEMATIC_ASSESSMENT General disorders MedDRA version 11.0 View